4//SEC Filing
YVER ANTOINE 4
Accession 0000899243-22-025479
CIK 0001847903other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:16 PM ET
Size
7.4 KB
Accession
0000899243-22-025479
Insider Transaction Report
Form 4
YVER ANTOINE
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2022-07-01$5.03/sh−9,100$45,797→ 730,597 total - Award
Ordinary Shares
2022-07-01+100,000→ 830,597 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted shares and does not represent a discretionary trade by the Reporting Person.
- [F3]The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in 10 equal quarterly instalments with the first such quarterly vesting being on September 30, 2022.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861878
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 6:16 PM ET
- Size
- 7.4 KB